CH500947A - Procédé de préparation de l'acide N-propionyl-E-amino-caproïque et de ses sels - Google Patents
Procédé de préparation de l'acide N-propionyl-E-amino-caproïque et de ses selsInfo
- Publication number
- CH500947A CH500947A CH670869A CH670869A CH500947A CH 500947 A CH500947 A CH 500947A CH 670869 A CH670869 A CH 670869A CH 670869 A CH670869 A CH 670869A CH 500947 A CH500947 A CH 500947A
- Authority
- CH
- Switzerland
- Prior art keywords
- propionyl
- caproic acid
- amino
- salts
- acid
- Prior art date
Links
- 229960002684 aminocaproic acid Drugs 0.000 title claims description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 159000000003 magnesium salts Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 2
- 229910052708 sodium Inorganic materials 0.000 abstract description 2
- 230000029663 wound healing Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 238000007696 Kjeldahl method Methods 0.000 description 3
- 238000003321 atomic absorption spectrophotometry Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101800000021 N-terminal protease Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR150414 | 1968-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH500947A true CH500947A (fr) | 1970-12-31 |
Family
ID=8649757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH670869A CH500947A (fr) | 1968-05-03 | 1969-05-01 | Procédé de préparation de l'acide N-propionyl-E-amino-caproïque et de ses sels |
Country Status (8)
| Country | Link |
|---|---|
| JP (2) | JPS5331856B1 (de) |
| AT (2) | AT294797B (de) |
| CH (1) | CH500947A (de) |
| DK (1) | DK128650B (de) |
| ES (1) | ES366715A1 (de) |
| FR (1) | FR1583842A (de) |
| NL (1) | NL6906745A (de) |
| SE (2) | SE369073B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2765109B1 (fr) * | 1997-06-25 | 2001-02-09 | Seppic Sa | Composition comprenant un lipoaminoacide et les constituants d'un extrait de plantes riches en tanins et utilisation en cosmetique |
| KR20250002731A (ko) | 2022-07-01 | 2025-01-07 | 미츠비시 파워 가부시키가이샤 | 가스 터빈 정익 및 가스 터빈 |
-
1968
- 1968-05-03 FR FR1583842D patent/FR1583842A/fr not_active Expired
-
1969
- 1969-04-29 SE SE608669A patent/SE369073B/xx unknown
- 1969-04-29 SE SE708972A patent/SE384133B/xx unknown
- 1969-05-01 DK DK241869A patent/DK128650B/da not_active IP Right Cessation
- 1969-05-01 CH CH670869A patent/CH500947A/fr not_active IP Right Cessation
- 1969-05-02 NL NL6906745A patent/NL6906745A/xx unknown
- 1969-05-02 JP JP3447869A patent/JPS5331856B1/ja active Pending
- 1969-05-02 ES ES366715A patent/ES366715A1/es not_active Expired
- 1969-05-02 AT AT423469A patent/AT294797B/de not_active IP Right Cessation
- 1969-05-02 AT AT213/71A patent/AT304765B/de not_active IP Right Cessation
- 1969-09-29 JP JP7810269A patent/JPS5022097B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK128650B (da) | 1974-06-10 |
| FR1583842A (de) | 1969-12-05 |
| SE369073B (de) | 1974-08-05 |
| JPS5331856B1 (de) | 1978-09-05 |
| SE384133B (sv) | 1976-04-26 |
| NL6906745A (de) | 1969-11-05 |
| AT294797B (de) | 1971-12-10 |
| ES366715A1 (es) | 1971-03-16 |
| AT304765B (de) | 1972-12-15 |
| JPS5022097B1 (de) | 1975-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2024419C (fr) | Nouveaux sels de metaux bivalents de l'acide n,n-di(carboxymethyl) amino-2cyano-3carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| CA1338561C (fr) | Esters et thioesters aromatiques, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique | |
| EP0260162B1 (de) | Bizyklische aromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0667330A1 (de) | Cyclohexanol-derivate enthaltende mischungen als mittel zur übertragung eines angenehm kühlen gefühls, verfahren zur herstellung dieser derivate sowie benötigte zwischenprodukte | |
| MX2011011762A (es) | Proceso para producir compuestos de p-mentano neo-enriquecidos. | |
| CA1328465C (fr) | Eicosanoides sulfures et leur application en pharmacie et en cosmetique | |
| CA1312333C (fr) | Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| CH500947A (fr) | Procédé de préparation de l'acide N-propionyl-E-amino-caproïque et de ses sels | |
| CH627648A5 (fr) | Nouveaux derives de 20,21-dinoreburnamenine, procede de preparation et compositions pharmaceutiques. | |
| Cope et al. | Cyclic Polyolefins. XX. Cycloöctatetraenecarboxylic Acid1 | |
| CA1155438A (fr) | Derives d'amino-14 steroides, et procede pour leur preparation | |
| JPS5851944B2 (ja) | フコウセイカゴウブツノセイホウ | |
| EP0360637B1 (de) | Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen | |
| CA1140155A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL | |
| EP0279954B1 (de) | Eicosattraynsäureamide, ihre Verwendung in der Arzneimittelkunde und Kosmetika, ihre Herstellung und Verfahren zur Herstellung von Eicosattraynsäure | |
| CH646181A5 (fr) | Procede de purification de l'acide ursodesoxycholique. | |
| EP0082040B1 (de) | 3,7a-Diazacyclohepta(j,k)fluorenderivate, ihre Herstellung und ihre therapeutische Verwendung | |
| CA1247122A (fr) | Derives insatures du camphre et leurs procedes de preparation | |
| CH299369A (fr) | Procédé de préparation d'un nouveau produit à odeur ambrée. | |
| JPH10182549A (ja) | アルケニルサリチル酸の分離精製方法 | |
| Bhati | Studies in the Sandalwood-Oil Series. I. The Structure, Synthesis, and Configuration of the Lactone of Tricycloekasantalic Acid1 | |
| CH334466A (fr) | Procédé de préparation de nouveaux esters d'hormones corticosurrénales | |
| JPS5822450B2 (ja) | イソロンギホラン−3−オ−ル | |
| HU184766B (en) | Process for preparing 5-chloro-2-oxo-bicyclo/2,2,1/heptane-7-carboxylic acid alkyl esters | |
| FR2889520A1 (fr) | Procede de preparation de l'iriflophenone et utilisation en tant qu'agent antioxydant et antiradicalaire dans des compositions alimentaires, cosmetiques et pharmaceutiques le contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |